3min chapter

The Heart of Healthcare | A Digital Health Podcast cover image

🏆 Meet the Shkreli Award "Winners" | Lown Institute President Dr. Vikas Saini

The Heart of Healthcare | A Digital Health Podcast

CHAPTER

Examining Profit Motives in Cancer Drug Dosing Strategies

This chapter examines Amgen's dosing strategy for Lumicross, raising concerns that financial incentives may compromise patient safety. It also critiques the FDA's approval process and the prevalence of maximum tolerated dosage approaches in drug development, suggesting a need for regulatory enhancements.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode